Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$126.46 - $235.05 $101,168 - $188,040
-800 Closed
0 $0
Q4 2021

Jan 19, 2022

BUY
$225.82 - $368.51 $180,656 - $294,808
800 New
800 $203,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Lattice Capital Management, LLC Portfolio

Follow Lattice Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lattice Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lattice Capital Management, LLC with notifications on news.